Treatment of infarcts through inhibition of nf-kappab

Details Treatment of infarcts through inhibition of nf-kappab Treatment of infarcts through inhibition of nf-kappab

A - Human Necessities

61

K

A61K 38/05 (2006.01) A61K 31/40 (2006.01) A61K 31/407 (2006.01)

Patent

CA 2281224

This invention is directed to treating ischemia by administering proteasome inhibitors, ubiquitin pathway inhibitors, agents that interfere with the activation of NF-B via the ubiquitin proteasome pathway, or mixtures thereof.

L'invention a trait au traitement de l'ischémie par l'administration d'inhibiteurs de protéasome, d'inhibiteurs de la voie d'ubiquitine, d'agents interférant avec l'activation de NF-?B via la voie d'ubiquitine-protéasome, ou de leurs mélanges.

Affiliated with

Also associated with

Rating

Treatment of infarcts through inhibition of nf-kappab does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of infarcts through inhibition of nf-kappab, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of infarcts through inhibition of nf-kappab will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1662472